PVI
DGX icon

Pine Valley Investments’s Quest Diagnostics DGX Stock Holding History

Pine Valley Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Sell
16,214
-3,741
-19% -$734K 0.14% 147
2026
Q1 		$3.91M Sell
19,955
-988
-5% -$192K 0.18% 129
2025
Q4 		$3.63M Sell
20,943
-1,226
-6% -$223K 0.17% 130
2025
Q3 		$4.22M Sell
22,169
-3,245
-13% -$576K 0.21% 114
2025
Q2 		$4.57M Sell
25,414
-346
-1% -$60.1K 0.25% 108
2025
Q1 		$4.36M Sell
25,760
-5,713
-18% -$939K 0.26% 102
2024
Q4 		$4.75M Sell
31,473
-3,235
-9% -$503K 0.28% 88
2024
Q3 		$5.39M Buy
34,708
+4,024
+13% +$601K 0.33% 75
2024
Q2 		$4.2M Buy
30,684
+2,893
+10% +$396K 0.28% 88
2024
Q1 		$3.7M Buy
27,791
+6,263
+29% +$813K 0.25% 93
2023
Q4 		$2.97M Buy
21,528
+4,627
+27% +$608K 0.21% 103
2023
Q3 		$2.06M Buy
16,901
+4,992
+42% +$665K 0.19% 132
2023
Q2 		$1.67M Buy
11,909
+534
+5% +$73.6K 0.16% 135
2023
Q1 		$1.52M Buy
+11,375
New +$1.63M 0.22% 99

Other funds holding DGX

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM

Pine Valley Investments's DGX Position: Q2 2026 in Review

Pine Valley Investments reduced its Quest Diagnostics (DGX) stake by 19% in Q2 2026, selling an estimated $734K and leaving 16,214 shares worth $3.44M. The position accounts for 0.14% of the portfolio, ranked #147.

Pine Valley Investments first reported a position in DGX in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.39M in Q3 2024. 536 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Pine Valley Investments held 16,214 shares of Quest Diagnostics worth $3.44M as of Q2 2026.
  • Pine Valley Investments sold 3,741 Quest Diagnostics shares in Q2 2026, an estimated $734K.
  • Quest Diagnostics made up 0.14% of Pine Valley Investments's portfolio in Q2 2026, its #147 holding.
  • Pine Valley Investments first reported a position in Quest Diagnostics in Q1 2023 and has held it in 14 quarters since.
  • Pine Valley Investments's Quest Diagnostics position peaked at $5.39M in Q3 2024.
  • 536 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.